Alzheimer's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been clinically diagnosed with Alzheimer's Disease.
- People who are between 18 and 80 years old.
- People who have signed a form giving their informed consent to take part.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have other conditions affecting the brain or nervous system.
- People who have blood clotting disorders, or who are taking blood-thinning medications.
- People who have skin conditions or diseases affecting the body's connective tissues.
- People who have other physical health conditions, mental health conditions, or abnormal test results that could affect their ability to participate or affect the study results.
- People who are unable to give informed consent.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Claudio Grassi, Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phone: +390630154966
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
Primary endpoints
Differences in zDHHC mRNA and protein expression levels between Alzheimer's disease (AD) models and control samples; Change in AD-associated deficits following zDHHC7 downregulation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 17 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.